Neoplastic skin diseases in organ transplant recipients

American Journal of Cancer

Volumn 1, Issue 2, 2002, Pages 109-120

  Euvrard, Sylvie ^a   Kanitakis, Jean ^a   Claudy, Alain ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AZATHIOPRINE; BLEOMYCIN; CARBOPLATIN; CIDOFOVIR; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOSCARNET; GANCICLOVIR; ISOTRETINOIN; OKT 3; PACLITAXEL; PREDNISOLONE; RETINOID; RITUXIMAB; TACROLIMUS; VINBLASTINE; VINCRISTINE; VINDESINE;

ANGIOSARCOMA; ANUS CANCER; BONE DISEASE; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FIBROXANTHOMA; GENETIC RISK; GENITAL TRACT CANCER; GRAFT REJECTION; HAIR LOSS; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LEIOMYOSARCOMA; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT FIBROUS HISTIOCYTOMA; MELANOMA; MERKEL CELL TUMOR; ORGAN TRANSPLANTATION; PATHOGENESIS; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SKIN CARCINOGENESIS; SKIN CARCINOMA; SUN EXPOSURE; TREATMENT INDICATION; VIRUS INFECTION; WART VIRUS; XEROSIS;

EID: 0003177075     PISSN: 11756357     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024669-200201020-00004     Document Type: Review

References (188)

1. Webb MC, Compton F, Andrews PA, et al. Skin tumours posttransplantation: a retrospective analysis of 28 years experience at a single centre. Transplant Proc 1997; 29: 828-30
2. Behrend M, Kolditz M, Kliem V, et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997; 29: 834-5
3. Hiesse C, Rieu P, Kriaa F, et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period. Transplant Proc 1997; 29: 831-3
4. Mihalov ML, Gattuso P, Abraham K, et al. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248-55
5. Montagnino G, Lorca E, Rantino A, et al. Cancer incidence in 854 kidney transplant recipients from a single institution: comparison with normal population and with patients under dialytic treatment. Clin Transplant 1996; 10: 461-9
6. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 11: 1282-3
7. Hartevelt MM, Bouwes Bavinck JN, Koote AMM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-9
8. Blohmé I, Larkö O. Skin lesions in renal transplant recipients after 10-23 years of immunosuppressive therapy. Acta Derm Venereol 1990; 70: 491-4
9. Birkeland S, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995; 60: 183-9
10. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86
11. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993; 7: 431-45
12. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9
13. Fernandez-Gonzalez A, Espana A, Redondo P. Solid tumors after heart transplantation. Ann Thorac Surg 1996; 62: 943-4
14. Ternesten-Bratel A, Kjellstrom C, Ricksten A. Specific expression of Epstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 1998; 66: 1524-9
15. Lampros TD, Cobanoglu A, Parker F, et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17: 586-91
16. Hoagland P, Moore K, King J, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30: 1124-6
17. Adamson R, Obispo E, Dychter S, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998; 30: 1124-6
18. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer 1999; 85: 1759-64
19. Ong CS, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27-34
20. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry-based study. Transplantation 2000; 70: 1479-84
21. Caforio AL, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102: 222-7
22. Pollard JD, Hanasono M, Mikulec A, et al. Head and neck cancer in cardiothoracic transplant recipients. Laryngoscope 2000; 110: 1257-61
23. Frezza EE, Fung JJ, Van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44: 1172-81
24. Jonas S, Rayes N, Neumann U, et al. De Novo malignancies after liver transplantation using Tacrolimus-based protocols of Cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141-50
25. Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-200
26. Bouwes-Bavinck JN, Hardie D, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 715-21
27. Bordea C, Cortina-Borja M, Wojnarowska F, et al. Distribution of upper limb skin cancers in relation to arteriovenous fistula side in renal transplant recipients. Transplantation 2001; 71: 143-5
28. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27: 1767-8
29. Penn I. De novo malignancy in pediatric organ transplant recipients. Pediatr Transplant 1998; 2: 56-63
30. Euvrard S, Kanitakis J, Cochat P, et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44: 932-9
31. Hoyo E, Kanitakis J, Euvrard S, et al. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Arch Dermatol Mar; 129 (3): 324-7
32. Kanitakis J, Narvaez D, Euvrard S, et al. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value. Br J Dermatol 1997; 136: 643-4
33. Narvaez D, Kanitakis J, Euvrard S, et al. Comparative nuclear morphometric analysis of aggressive and non-aggressive squamous cell carcinomas of the skin. Acta Derm Venereol 1997; 77: 115-7
34. Boyle J, Briggs JD, Mackie RM, et al. Cancer, warts, and sunshine in renal transplant patients. Lancet 1984; 1: 702-5
35. Sheil AGR, Flavel S, Disney APS, et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc 1987; 19: 2214-6
36. Glover MT, Deeks JJ, Raftery MJ, et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients [letter]. Lancet 1997; 349: 398
37. Hoshida Y, Tsukama H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517-20
38. Bouwes-Bavinck JN, de Boers A, Vermeer BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242-9
39. Butt A, Roberts DL. Renal transplant recipients and protection from sun: need for education. Lancet 1997; 349: 179-80
40. Seukeran DC, Newstead CG, Cunliffe WJ. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998; 138: 301-3
41. Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697-701
42. Kurimoto I, Streilein JW. UV-induced immunosuppression. In: Euvrard S, Kanitakis J, Claudy A. editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 29-36
43. Galvao MM, Sotto MN, Kihara SM, et al. Lymphocyte subsets and Langerhans cells in sun-protected and sun-exposed skin of immunosuppressed renal allograft recipients. J Am Acad Dermatol 1998; 38: 38-44
44. Servitje O, Seron D, Ferrer I, et al. Quantitative and morphometric analysis of Langerhans cells in non-exposed skin in renal transplant patients. J Cutan Pathol 1991; 18: 106-11
45. Ducloux D, Carron PL, Rebibou JM, et al. CD4 lymphopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65: 1270-2
46. Arends MJ, Benton EC, McLaren KM, et al. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997; 75: 722-8
47. Euvrard S, Pouteil-Noble C, Kanitakis J, et al. Successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous cell carcinomas. N Engl J Med 1992; 327: 1924-7
48. Barroso-Vicens E, Ramirez G, Rabb H. Multiple primary malignancies in a renal transplant patient. Transplantation 1996; 61: 1655-6
49. Kanitakis J, Euvrard S, Montazeri A, et al. Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996; 35: 262-4
50. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623-8
51. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59: 212-7
52. Barr B, Benton EC, McLaren K, et al. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-9
53. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and non carcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198-206
54. Chardonnet Y, Viac, J, Euvrard S. Warts and squamous cell carcinomas in organ transplant patients: is the human papillomavirus responsible for carcinogenesis? Eur J Dermatol 1997; 7: 5-11
55. De Villiers EM, Lavergne D, McLaren K, et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356-61
56. Harwood CA, McGregor JM, Proby CM, et al. Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol 1999; 52: 249-53
57. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-97
58. Berkhout R, Bouwes-Bavinck J, ter Schegget J. Persistence of Human Papillomavirus DNA in benign and (pre) malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-96
59. de Jong-Tieben L, Berkhout R, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44-9
60. Boxman I, Berkhout R, Mulder L, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 712-5
61. Boxman I, Mulder L, Russel A, et al. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 1999; 141: 246-9
62. Shamanin V, Zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88: 802-11
63. McGregor JM, Berkhout RJ, Rozycka M, et al. P53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997; 15: 1737-40
64. Cairey-Remonnay S, Humbey O, Mougin C, et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epethelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with HPV status. J Invest Dermatol 2002; In press
65. Cathomas G, Tamm M, McGandy CE, et al. Absence of Kaposi's sarcoma-associated human herpes virus 8 in transplantation-related tumors other than Kaposi's sarcoma. Transplant Proc 1997; 29: 836-7
66. Dupin N, Gorin I, Escande JP, et al. Lack of evidence of any association between human herpesvirus 8 and various skin tumors from both immunocompetent and immunosuppressed patients [letter]. Arch Dermatol 1997; 133: 537
67. Lebbé C, Tatoud R, Morel P, et al. Human Herpesvirus 8 sequences are not detected in epithelial tumors from patients receiving transplants [letter]. Arch Dermatol 1997; 133: 111
68. Thomas DW, Ramsahoye B, Jasani B, et al. Epstein-Barr Virus in squamous cell carcinoma after renal transplantation. Transplantation 1995; 60: 390-2
69. Huston BM, Maia DM. Absence of latent Epstein-Barr virus in cutaneous squamoproliferative lesions after solid organ transplantation. Mod Pathol 1997; 10: 1188-93
70. Kolhler S, Kamel OW. Chang PP, et al. Absence of herpesvirus 8 and Epstein-Barr virus genome sequences in cutaneous epithelial neoplasms arising in immunosuppressed organ-transplant patients. J Cutan Pathol 1997; 24: 559-63
71. Bouwes-Bavinck JN, Claas F, Hardie D, et al. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108: 708-11
72. Marshall SE, Bordea C, Haldar N, et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 2000; 58: 2186-93
73. Van Zuuren E, Posma A, Scholtens R, et al. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients. J Am Acad Dermatol 1994; 31: 760-4
74. Euvrard S. General guidelines. In: Euvrard S, Kanitakis J, Claudy, et al., editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 29-36
75. Euvrard S, Kanitakis J, Thivolet J, et al. Retinoids for the management of dermatological complications of organ transplantation. Biodrugs 1997; 3: 176-84
76. Euvrard S, Verschoore M, Touraine JL, et al. Topical retinoids for warts and keratoses in transplant recipients. Lancet 1992; 340: 48-9
77. Rook AH, Jaworsky C, Nguyen T, et al. Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 1995; 59: 714-9
78. Christiansen TN, Freije JE, Neuburg M, et al. Cutaneous squamous cell carcinoma metastatic to the parotid gland in a transplant patient. Clin Transplant 1996; 10: 561-3
79. Magnone M, Holley J, Shapiro R, et al. Interferon α-induced acute renal allograft rejection. Transplantation 1994; 59: 1068-70
80. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611-6
81. Euvrard S, Kanitakis J, Chardonnet Y, et al. External anogenital lesions in organ transplant recipients. Arch Dermatol 1997; 133: 175-8
82. Volgger B, Marth C, Zeimet A, et al. Fulminant course of a microinvasive vulvar carcinoma in an immunosuppressed woman. Gynecol Oncol 1997; 65: 177-9
83. Longuet M, Cassonet P, Orth G. A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol 1996; 34: 1859-62
84. Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-9
85. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274-8
86. Greene MH. Malignant melanoma in renal transplant recipients. Lancet 1981; II: 1196-9
87. Lévêque L, Dalac S, Dompmartin A, et al. Melanoma in organ transplant patients [in French]. Ann Dermatol Venereol 2000; 127: 160-5
88. Grob JJ, Bastuji-Garin S, Vaillant L, et al. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. J Invest Dermatol 1996: 197: 694-7
89. Kanitakis J, Euvrard S, Faure M, et al. Caractères prolifératifs des naevus chez les enfants greffés d'organe. Ann Dermatol Vénéréol 1999; 126: 687-90
90. Smith C, McGregor J, Barker J, et al. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28: 51-5
91. Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997; 194: 17-9
92. Penn I, Brunson ME. Cancers after cyclosporine therapy. Transplant Proc 1988; 20: 885-92
93. Bismuth H, Samuel D, Venancie P, et al. Development of Kaposi's sarcoma in liver transplant recipients: characteristics, management and outcome. Transplant Proc 1991; 23: 1438-9
94. Farge D. Kaposi's sarcoma in organ transplant recipients. Eur J Med 1993; 2: 339-43
95. Besnard V, Euvrard S, Kanitakis J, et al. Kaposi's sarcoma after liver transplantation. Dermatology 1996; 193: 100-4
96. Kadry Z, Bronsther O, Van Thiel DH, et al. Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin Tranplant 1993; 7: 188-94
97. Rezeig MA, Fashir MB, Hainau B, et al. Kaposi's sarcoma in liver transplant recipients on FK 506: two case reports. Transplantation 1997; 63: 1520-1.
98. Penn I, Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485-91
99. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67: 759-65
100. Francès C, Lagrange S, Kaposi's sarcoma. In: Euvrard S, Kanitakis J, Claudy A. et al., editors. Skin diseases after organ transplantation. Paris: John Libbey Eurotext, 1998: 131-8
101. Lesnoni La Parola I, Masini C, Nanni G, et al. Kaposi's sarcoma in renal-transplant recipients: experience at the catholic university of Rome, 1988-1996. Dermatology 1997; 194: 229-33
102. Quinibi W, Barri Y, Al-Furayh O, et al. Kaposi's sarcoma in renal transplant re-cipients: a report on 26 cases from a single institution. Transplant Proc 1993; 25: 1402-5
103. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64: 669-73
104. Halmos O, Inturri P, Galligioni A, et al. Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon. Clin Transplant 1996: 10: 374-8
105. Colina F, Lopez-Rios F, Lumbreras C, et al. Kaposi's sarcoma developing in a liver graft. Transplantation 1996; 61: 1779-81
106. Al-Sulairnan MH, Mousa DH, Rassoul Z, et al. Transplant related Kaposi sarcoma in children. Nephrol Dial Transplant 1994; 9: 443-5
107. Ozen S, Saatci U, Karaduman A, et al. Kaposi's sarcoma in a paediatric renal transplant recipient. Nephrol Dial Transplant 1996; 11: 1162-3
108. Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol 1990; 29: 56-63
109. Burgert S, Strickman N, Carrol C, et al. Cardiac Kaposi's sarcoma following heart transplantation. Catheter Cardiovasc Interv 2000; 49: 208-12
110. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol 1996; 134: 44-6
111. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial origin of Kaposi's sarcoma tumor cells. Lab Invest 1999; 79: 243-51
112. Kaaya E, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer 1992; 28: 1890-4
113. Delabesse E, Oksenhendler E, Lebbé C, et al. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997; 50: 664-8
114. Rabkin CS, Jane S, Lash A, et al. Monoclonal origin of mulficentric Kaposi's sarcoma lesions. N Engl J Med 1997; 336: 988-93
115. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181-5
116. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma associated herpesvirus (HHVS). Proc Natl Acad Sci USA 1996; 93: 14862-7
117. Cathomas G. Human herpes virus 8: a new virus discloses its face. Virchows Arch 2000; 436: 195-206
118. Boshoff C. Kaposi's sarcoma associated herpesvirus. Cancer Surv 1998; 33: 157-90
119. Alkan S, Karcher DS, Ortiz A, et al. Human herpesvirus-8/Kaposi's sarcomaassociated herpesvirus in organ transplant patients with immunosuppression. Br J Haematol 1997; 96: 412-4
120. Flore O, Rafii S, Ely S, et al. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998; 394: 588-92
121. Muralidhar S, Pumfrey A, Hassani M, et al. Identification of kaposin (open reading frame K 12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 1998; 72: 4980-8
122. Lebbé C, Agbalika F, de Crémoux P, et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133: 25-30
123. Kedda MA, Margolius L, Kew MC, et al. Kaposi's sarcoma associated herpes virus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients. Clin Transplant 1996; 10: 429-31
124. Noel JC, De Thier F, Heenen M, et al. HHV-8 is associated with recurrent Kaposi's sarcoma in a renal transplant recipient. Transplant Int 1997; 10: 81-2
125. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799-802
126. Pozo F, Tenorio A, De la Mata M, et al. Persistent Human herpesvirus 8 viremia before Kaposi's sarcoma development in a liver transplant recipient. Transplantation 2000; 70: 395-7
127. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826-9
128. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with or without Kaposi's sarcoma. Nat Med 1996; 2: 925-8
129. Francès C, Mouquet C, Marcellin AG, et al. Outcome of kidney transplant recipients with previous human herpevirus-8 infection. Transplantation 2000; 69: 1776-9
130. Cattani P, Nanni G, Capuano M, et al. Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients. Transplant Proc 2000; 32: 526-7
131. Regamey N, Tamm M, Wernli M, et al. Transmission of Human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339: 1358-63
132. Bottalico D, Santabosti Barbone G, Gianeaspro V, et al. Post-transplantation Kaposi's sarcoma appearing simultaneously in same cadaver donor renal transplant recipients. Nephrol Dial Transplant 1997; 12: 1055-7
133. Hussein M, Mooij J, Roujouleh H. Regression of posttransplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate niofetil instead. Nephrol Dial Transplant 2000; 15: 1103-4
134. Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol 1997; 15: 2371-7
135. Medveczky MM, Horvath E, Lund T, et al. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpes virus. AIDS 1997; 11: 1327-32
136. Al-Sulaiman MH, Mousa DH, Dhar JM, et al. Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression? Am J Nephrol 1992; 12: 384-6
137. Doutrelepont JM, De Pauw L, Gruber SA, et al. Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation 1996; 62: 463-6
138. Euvrard S, Kanitakis J, Bosshard S, et al. No recurrence of posttranspiantation Kaposi's sarcoma three years after renal retransplantation. Transplantation 2002; 73: 297-9
139. van Gorp J, Doornewaard H, Verdonck L, et al. Posttransplant T-cell lymphoma: report of three cases and review of the literature. Cancer 1994: 73: 3064-72
140. Ahmed I. Cutaneous B cell post-transplant lymphoproliferative disorder [abstract]. Am J Dermatopathol 2000; 22: 352
141. Chai C, White W, Shea C, et al. Epstein-Barr virus-associated lymphoproliferative disorders primarily involving the skin. J Cutan Pathol 1999; 26: 242-7
142. Gorithier D, Hartman G, Holley J. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 1992; 19: 600-3
143. Kerr P, Gohn R, Robinson-Bostom L. Cutaneous Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder [abstract]. J Cutan Pathol 2000; 27: 543A
144. McGregor J, Yu C, Lu Q, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol 1993; 29: 549-54
145. Mozzanica N, Cattaneo A, Fracchiolla N, et al. Posttransplantation cutaneous B cell lymphoma with monoclonal Epstein-Barr virus infection responding to acyclovir and reduction in immunosuppression. J Heart Lung Transplant 1997; 16: 964-8
146. Schumann K, Oriba H, Bergfeld W, et. al. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol 2000: 42: 923-6
147. Whittam L, Coleman R, McDonald D. Plasma cell tumour in a renal transplant recipient. Clin Exp Dermatol 1996; 21: 367-9
148. Tas S, Simonart T, Dargent J, et al. Granulomatose lymphomatoïde à localisation cutanée isolée après une transplantation cardio-pulmonaire. Ann Dermatol Venereol 2000; 127: 488-91
149. Pascual J, Torrelo A, Teruel J, et al. Cutaneous T cell lymphomas after renal transplantation. Transplantation 1992; 53: 1143-5
150. Ward H, Russo G, McBurney E, et al. Posttransplant primary cutaneous T-cell lymphoma. J Am Acad Dermatol 2001; 44: 675-80
151. Defossez C, Carmi E, Poulain JF, et al. Lymphome T cutané chez une transplantée rénale [abstract]. Nouv Dermatol 2001; 20 Suppl. 3: 25
152. Milpied V, Vasseur B, Parquet N, et al. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000; 11 Suppl. 1: 113-6
153. Heinzerling L, Urbanek M, Funk J, et al. Reduction of tumor burden and stablization of disease by systemic therapy with anti-CD20 antibody (Rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer 2000; 89: 1835-44
154. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52-9
155. Somers G, Tesoriero A, Hartland E, et al. Multiple leiomyosarcomas of both donor and recipient origin in a heart-lung transplant patient. Am J Surg Pathol 1998; 22: 1423-8
156. Lee E, Locker J, Malesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19-25
157. Kingma D, Shad A, Tsokos M, et al. Epstein-Barr virus (EBV)-associated smooth muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV associated large cell lymphomas. Am J Surg Pathol 1996: 20: 1511-9
158. Van Gelder T, Vuzevski V, Weimar W. Epstein-Barr virus in smooth muscle tumors [letter]. N Engl J Med 1995; 332: 1719
159. Uribe-Uribe N, Aviles-Salas A, Orozco-Estevez H, et al. Leiomyosarcoma associated with Epstein-Barr virus in an adult with renal transplant [in Spanish]. Rev Invest Clin 1998; 50: 255-8
160. Dei Tos A, Maestro R, Doglioni C, et al. Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol 1994; 145: 11-7
161. Paquet P, Pierard G. Invasive atypical fibroxanthoma and eruptive actinic keratoses in a heart transplant recipient. Dermatology 1996; 192: 411-3
162. Hafner J, Künzi W, Weinreich T. Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999; 198: 29-32
163. Bessis D, Sotto A, Roubert P, et al. Endothelin-secreting angiosarcoma occurring at the site of an arteriovenous fistula for haemodialysis in a renal transplant recipient. Br J Dermatol 1998; 138: 361-2
164. Wehrli B, Janzen D, Shokeir O, et al. Epithelioid angiosarcoma arising in surgically constructed arteriovenous fistula. Am J Surg Pathol 1998; 22: 1154-9
165. Medioni L, Costes V, Leray H, et al. Angiosarcome sur fistule artérioveineuse chez un transplanté rénal. Ann Pathol 1996; 16: 200-2
166. Conlon P, Daly T, Doyle G, et al. Angiosarcoma at the site of a ligated arteriovenousfistula in a renal transplant recipient. Nephrol Dial Transplant 1993; 8: 259-62
167. Parrott N, Scott P, Freemont A, et al. Angiosarcoma in an arteriovenous fistula following successful renal transplantation-a case report. Transplantation 1993; 55: 676-7
168. Kibe Y, Kishimoto S, Katoh N, et al. Angiosarcoma of the scalp associated with renal transplantation. Br J Dermatol 1997; 136: 752-6
169. Alpers C, Biava C, Salvatierra O. Angiosarcoma following renal transplantation. Transplant Proc 1982; 14: 448-51
170. Studniberg H, Rivers J, Cooke B, et al. The coexistence of lymphangiosarcoma and Kaposi's sarcoma in a renal transplant recipient. Cancer 1991; 68: 2330-5
171. Penn I, First M. Merkel's cell carcinoma in organ recipients. Transplantation 1999; 68: 1717-21
172. Formica M, Basolo B, Funaro L, et al. Merkel cell carcinoma in renal transplant recipient. Nephron 1994; 68: 399
173. Gilaberte M, Pujol R, Sierra J, et al. Merkel cell carcinoma developing after bone marrow transplantation. Dermatology 2000; 201: 80-2
174. Gooptu C, Woolons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137: 637-41
175. Pham S, Kormos R, Landreneau R, et al. Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995; 60: 1623-6
176. Plunket T, Harris A, Ogg C, et al. The treatment of Merkel cell carcinoma and its association with immunosuppression. Br J Dermatol 1998; 139: 345-6
177. Stempfle H, Mudra H, Angermann C, et al. Rapid growth of cutaneous neuroendocrine (Merkel cell) carcinoma during treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. J Heart Lung Transplant 1993; 12: 501-3
178. Urbatsch A, Sams M, Urist M, et al. Merkel cell carcinoma occurring in renal transplant recipients. J Am Acad Dermatol 1999; 41: 289-91
179. Williams R, Morgan M, Mathieson I, et al. Merkel cell carcinoma in a renal transplant patient: increased incidence? Transplantation 1998; 27: 1396-7
180. Douds A, Mellotte G, Morgan H. Fatal Merkel-cell tumour (cutaneous neuroendocrine carcinoma) complicating renal transplantation. Nephrol Dial Transpl 1995; 10: 2346-8
181. Baron J, Sanchez C, Garcia P. Merkel cell carcinoma in a kidney transplant patient. Rev Clin Esp 2001; 201: 223
182. Lok C, Luong S, Chaby G, et al. Cutaneous echography at a renal grafted patient presenting multiple histiocytofibromes localised [abstract; in French]. Nouv Dermatol 1998; 17: 627
183. Boivin S, Catteau B, Provot F, et al. Histiocytofibromes atypiques chez deux patients greffés rénaux [abstract]. Ann Dermatol Venereol 2000; 127 Suppl. 4: 219
184. Lai K, Lai F, King W, et al. Dermatofibrosarcoma protuberans in a renal transplant patient. Aust N Z Surg 1995; 65: 900-2
185. Hadzic N, Pritchard J, Webb D, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation 2000; 70: 815-9
186. Miller M, Tonsgard J, Soltani K. Late-onset neurofibromatosis in a liver transplant recipient. Int J Dermatol 2000; 39: 376-9
187. Lemeur Y, Bédane C, Clavère P, et al. A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrol Dial Transplant 1997; 12: 1271-3
188. Otley CC. Organization of a speciality clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatol Surg 2000; 26: 709-12